StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MTEX

Mannatech, Incorporated

MTEX Nasdaq Medicinal Chemicals & Botanical Products EDGAR ↗
$4.95
+0.07 +1.43%

Key statistics

from XBRL data in SEC filings
Market cap
$9.55M
Revenue (TTM)
$108M
Net income (TTM)
-$12.7M
EPS (TTM)
$-8.00
P/E ratio
Dividend yield
4.04%
Free cash flow
-$4.32M
Cash
$7.01M
Total assets
$29.9M
Gross margin
74.9%
52-week range
$3.80 – $12.45

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jun 8, 2026 8-K Shareholder vote results Jun 3, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Delisting notice or listing-rule failure Apr 24, 2026 8-K Results of operations (earnings release) Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Other events Apr 2, 2026 8-K Director or officer change Mar 24, 2026 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement Sep 12, 2025 8-K Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Director or officer change Jul 24, 2025 8-K Director or officer change Jun 26, 2025 8-K Shareholder vote results Jun 4, 2025 8-K May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Mar 26, 2025 10-K Fiscal year ended 2024-12-31 Mar 26, 2025 8-K Director or officer change Nov 26, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Delisting notice or listing-rule failure; Other events Sep 27, 2024 8-K Delisting notice or listing-rule failure; Other events Aug 22, 2024 8-K Results of operations (earnings release) Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Entered a material agreement; Director or officer change Jul 2, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Results of operations (earnings release) May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Entered a material agreement; Took on a direct financial obligation Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Director or officer change Mar 14, 2024 8-K Director or officer change Jan 12, 2024 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 7, 2023 8-K Results of operations (earnings release) Aug 14, 2023